QIAGEN receives U.S. FDA EUA for QIAstat-Dx test kit, first and only syndromic solution integrating detection of SARS-CoV-2 coronavirus

QIAGEN names Thierry Bernard as Chief Executive Officer

QIAGEN launches QIAstat-Dx test kit for detection of SARS-CoV-2 coronavirus in Germany following derogation by BfArM

QIAGEN launches QIAstat-Dx test kit for detection of SARS-CoV-2 coronavirus in Europe following CE marking

QIAGEN dramatically ramping up global production capacity for RNA extraction kits for use in detection of SARS-CoV-2 coronavirus

QIAGEN gains BARDA funding for approval process of QIAstat-Dx test kit for SARS-CoV-2 coronavirus 

Thermo Fisher Scientific to Acquire QIAGEN N.V.

Ad hoc Announcement according to Art. 17 Market Abuse Regulation

QIAGEN announces 20-F annual report filing for 2019 results

QIAGEN announces worldwide shipments of QIAstat-Dx test kits for SARS-CoV-2